Clene Announces $4 Million Registered Direct Offering
Clene priced a $4 million registered direct offering of 1,219,513 shares at $3.28 per share, sold to existing shareholders and priced at market under Nasdaq rules. The raise was led by Board Chairman David Matlin alongside founding investor Kensington Capital Holdings, the company's CEO, and other existing shareholders, with no placement agent or underwriter involved. Proceeds, combined with existing cash, are expected to fund operations through mid-first quarter 2027, supporting the regulatory dialogue and filings for lead asset CNM-Au8, expanded access protocols, potential commercialization, and manufacturing expansion.
Key figures
- Deal Value Usd
- 4000000
- Offering Price
- 3.28
- Shares Offered
- 1219513
- Pricing
- at market under Nasdaq rules
- Cash runway
- mid-first quarter 2027
- Placement agent
- No
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.